Bowel cancer drug added to subsidy list

AUSTRALIANS living with aggressive bowel cancer will have access to a more affordable treatment after it was added to the Pharmaceutical Benefits Scheme. More than 15,000 Australians are diagnosed with bowel cancer every year, 10 per cent of whom have an aggressive form with poor prognosis. Bowel cancer is the second-deadliest cancer in Australia and […]